Moderna, Inc. (MRNA)
223.20
-8.15
(-3.52%)
USD |
NASDAQ |
Nov 13, 16:00
217.21
-5.99
(-2.68%)
After-Hours: 19:59
Moderna EPS Diluted (Quarterly) : 0.3791 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3791 |
| June 30, 2026 | -1.965 |
| March 31, 2026 | -3.40 |
| December 31, 2025 | -2.107 |
| September 30, 2025 | -0.5128 |
| June 30, 2025 | -2.126 |
| March 31, 2025 | -2.516 |
| December 31, 2024 | -2.909 |
| September 30, 2024 | 0.0326 |
| June 30, 2024 | -3.331 |
| March 31, 2024 | -3.076 |
| December 31, 2023 | 0.5494 |
| September 30, 2023 | -9.528 |
| June 30, 2023 | -3.622 |
| March 31, 2023 | 0.1951 |
| December 31, 2022 | 3.617 |
| September 30, 2022 | 2.532 |
| June 30, 2022 | 5.243 |
| March 31, 2022 | 8.584 |
| Date | Value |
|---|---|
| December 31, 2021 | 11.29 |
| September 30, 2021 | 7.680 |
| June 30, 2021 | 6.450 |
| March 31, 2021 | 2.840 |
| December 31, 2020 | -0.6869 |
| September 30, 2020 | -0.592 |
| June 30, 2020 | -0.3067 |
| March 31, 2020 | -0.3518 |
| December 31, 2019 | -0.3715 |
| September 30, 2019 | -0.3725 |
| June 30, 2019 | -0.4099 |
| March 31, 2019 | -0.4032 |
| December 31, 2018 | -0.4383 |
| September 30, 2018 | -0.2638 |
| June 30, 2018 | -0.2826 |
| March 31, 2018 | -0.2279 |
| December 31, 2017 | -0.1244 |
| September 30, 2017 | -0.2051 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.896 |
| Vaxcyte, Inc. | -1.995 |
| Twist Bioscience Corp. | 0.00 |
| BioNTech SE | 0.8399 |
| Vir Biotechnology, Inc. | -0.5686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 162.00M |
| Revenue (Quarterly) | 1.313B |
| Total Expenses (Quarterly) | 1.151B |
| Enterprise Value | 92.52B |
| Gross Profit Margin (Quarterly) | 70.60% |
| Profit Margin (Quarterly) | 12.34% |
| Earnings Yield | -3.18% |
| Normalized Earnings Yield | -3.178 |